Skip to main content
. 2018 Jun 26;62(7):e02375-17. doi: 10.1128/AAC.02375-17

FIG 6.

FIG 6

(a) Mean plasma and lung concentration-time profiles of SKLB-TB1001 and its metabolite M6 after a p.o. dose of SKLB-TB1001 at 50 mg/kg in male CD1 mice (n = 3/time point). (b) Mean plasma concentration-time profiles of SKLB-TB1001 after i.v. and p.o. doses in male SD rats (n = 3).